Zimmer Partners’s Inspire Medical Systems INSP Stock Holding History

Zimmer Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,000	Closed	-$535K	–	104
2018 Q2	$535K	Buy	+15,000	New	+$484K	0.01%	93

Other funds holding INSP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Zimmer Partners's INSP Position: Q3 2018 in Review

Zimmer Partners sold out of Inspire Medical Systems (INSP) in Q3 2018, closing a stake of 15,000 shares — an estimated $535K sold.

Zimmer Partners first reported a position in INSP in Q2 2018 and held it in 1 quarter. The position peaked at $535K in Q2 2018. 87 funds tracked by Wall St. Rank hold INSP as of Q3 2018.

Zimmer Partners reported no remaining Inspire Medical Systems position as of Q3 2018 after selling out during the quarter.
Zimmer Partners sold 15,000 Inspire Medical Systems shares in Q3 2018, an estimated $535K.
Zimmer Partners first reported a position in Inspire Medical Systems in Q2 2018 and held it in 1 quarter.
Zimmer Partners's Inspire Medical Systems position peaked at $535K in Q2 2018.
87 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2018.

Based on Zimmer Partners's 13F filing for Q3 2018, filed 14 Nov 2018.